Paper Details

  1. Home
  2. Paper Details

Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cells.

Author: BlonskiJerzy Z, HanausekMalgorzata, KilianskaZofia M, KobylinskaAgnieszka, RobakTadeusz, WalaszekZbigniew

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study investigates the correlation between expression of Bax and Bcl-2 (Bax/Bcl-2 ratio) in B-CLL cells and the response to chemotherapy. The results suggest that the Bax/Bcl-2 ratio is elevated in patients treated with cladribine combined with mitoxantrone and cyclophosphamide, indicating enhanced apoptosis induction.
Paper Details　
Original Abstract of the Article :
The present study investigated a correlation between expression of Bcl-2 family members, Bax and Bcl-2 (the Bax/Bcl-2 ratio values) in B-CLL cells in vivo and the response of these cells to chemotherapy. Western blot technique combined with videodensitometry was used for Bax and Bcl-2 determination ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/14767525

データ提供：米国国立医学図書館（NLM）

Examining the In Vivo Effects of Cladribine on B-CLL Cells

In the realm of [cancer research], understanding the intricate dance between chemotherapy and cancer cells is paramount. This study delves into the in vivo effects of cladribine, a chemotherapy drug, on B-CLL cells, a type of leukemia. Employing the meticulous [Western blot technique], researchers sought to unravel the intricate interplay between Bax and Bcl-2 proteins, key players in the cellular life-or-death decision. The study revealed that cladribine, when combined with other chemotherapy agents like cyclophosphamide and mitoxantrone, effectively elevated the Bax/Bcl-2 ratio in B-CLL cells, leading to increased apoptosis, or programmed cell death. This finding underscores the potential of these drug combinations to effectively combat B-CLL.

Combined Therapy: A Powerful Weapon Against B-CLL

The results clearly indicate that the combination of cladribine with mitoxantrone and cyclophosphamide significantly enhances the Bax/Bcl-2 ratio in B-CLL cells. This ratio is a critical indicator of cell fate, with a higher ratio promoting apoptosis, or cell death. The observed increase in apoptosis suggests that this combined therapy may be a promising approach for treating B-CLL.

Implications for B-CLL Treatment

The findings from this study suggest that combined chemotherapy with cladribine, mitoxantrone, and cyclophosphamide holds significant promise for the treatment of B-CLL. This approach could lead to more effective treatment strategies and potentially improved outcomes for patients.

Dr. Camel's Conclusion

The fascinating dance between cladribine and B-CLL cells is a testament to the complex nature of chemotherapy. This study unveils a potential strategy for battling B-CLL, showcasing the power of combined therapies. The results, like grains of sand in a vast desert, contribute to our understanding of cancer and pave the way for better treatments in the future.
Date :
  1. Date Completed 2004-10-07
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

14767525

DOI: Digital Object Identifier

14767525

Related Literature

Article Analysis
・Effects of cladribine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.